RIGHT ON BRANDS INTRODUCES NEW PRODUCT LINE
February 22, 2022 08:00 ET
|
Right On Brands, Inc.
Dallas, TX, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...
Right on Brands, Inc. Reports Record 3rd Quarter and New Store in Laredo, Texas
February 09, 2022 13:00 ET
|
Right On Brands, Inc.
Dallas, TX, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON) a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...
Right on Brands, Inc. Reports Record 2nd Quarter
November 16, 2021 08:30 ET
|
Right On Brands, Inc.
Dalles, Texas, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based smokables, beverages, tinctures, and...
RIGHT ON BRANDS FILES 10Q
August 13, 2021 09:10 ET
|
Right On Brands, Inc.
Dallas, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Right on Brands, Inc.™ (OTC Pink: RTON), a fully reporting SEC filer and developer of a broad line of hemp-based foods, beverages, tinctures, and...
BIOSPECIFICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of BSTC and Encourages Investors to Contact the Firm
October 19, 2020 13:15 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
July 31, 2019 08:10 ET
|
Helsinn Healthcare S.A.
Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada DUBLIN and LUGANO, July 31, 2019 -- Endo International plc (NASDAQ: ENDP), and Helsinn, a Swiss...
Emerald Health Therapeutics’ Licensed Endo Product Wins Taste For Life’s 2019 Essentials Supplement Award in the U.S.
March 07, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its joint venture partner’s, (Emerald Health Bioceuticals or...
Emerald Health Therapeutics’ Licensed Endo Product Line Gains Boost with Entry into Whole Foods Market Stores Across US
January 29, 2019 06:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its joint venture partner, San Diego-based...
Investors for Opioid Accountability Commends Endo International plc for Board of Directors’ Opioid Oversight Report
December 06, 2018 09:05 ET
|
UAW Retiree Medical Benefits Trust
Detroit, Michigan, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Investors for Opioid Accountability (IOA), a coalition of 53 institutional investors with over $3.4 trillion in assets, commends Endo...
Emerald Joint Venture Receives Licenses from Health Canada to Sell Proprietary Products Supporting the Endocannabinoid System
December 04, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
Endo Brain recently awarded 2018 SupplySide Editor’s Choice Award for Brain Health Planned mid-2019 product launch will open natural health product, grocery, and pharmacy store channels to Emerald...